Evidence map›Paper›PMID 41691119›Full record

ArticleCommunications chemistry2026

A hierarchical interaction message net for accurate molecular property prediction.

Huiyang Hong, Xinkai Wu, Hongyu Sun, Chaoyang Xie, Qi Wang, Yuquan Li

Abstract read
In one paragraph

Article in Communications chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Huiyang HongState Key Laboratory of Public Big Data, College of Computer Science and Technology, Guizhou University, Guizhou, China.
Xinkai WuState Key Laboratory of Public Big Data, College of Computer Science and Technology, Guizhou University, Guizhou, China.
Hongyu SunState Key Laboratory of Public Big Data, College of Computer Science and Technology, Guizhou University, Guizhou, China.
Chaoyang XieState Key Laboratory of Public Big Data, College of Computer Science and Technology, Guizhou University, Guizhou, China.
Qi WangState Key Laboratory of Public Big Data, College of Computer Science and Technology, Guizhou University, Guizhou, China. qiwang@gzu.edu.cn.ORCID http://orcid.org/0000-0002-6269-0196
Yuquan LiState Key Laboratory of Public Big Data, College of Computer Science and Technology, Guizhou University, Guizhou, China. yvquan.li@gzu.edu.cn.ORCID http://orcid.org/0000-0003-2756-0449

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Discovering molecules with desirable molecular properties, including ADMET profiles, is of great importance in drug discovery. Existing approaches typically employ deep learning models, such as Graph Neural Networks and Transformers, to predict these molecular properties by learning from diverse chemical information. However, these models often lack mechanisms for effective interaction among multi-level features. To address these limitations, we propose a Hierarchical Interaction Message Passing Mechanism, which serves as the foundation of our model, the Hierarchical Interaction Message Net (HimNet). Our method enables interaction-aware representation learning across atomic, motif, and molecular levels via hierarchical attention-guided message passing. This design allows HimNet to effectively balance global and local information, ensuring rich and task-relevant feature extraction for downstream property prediction tasks. We systematically evaluate HimNet on eleven datasets, including eight widely-used MoleculeNet benchmarks and three challenging, high-value datasets for metabolic stability, malaria activity, and liver microsomal clearance, covering a broad range of pharmacologically relevant properties. Extensive experiments demonstrate that HimNet achieves the best or near-best performance in most molecular property prediction tasks. We believe that HimNet offers an accurate and efficient solution for molecular activity and ADMET property prediction, contributing significantly to advanced decision-making in the early stages of drug discovery.

Identifiers

PMID41691119
PMCPMC13065987

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.